-
GPCR Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Structure Therapeutics (GPCR)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 172.13 mm | 172.13 mm | 172.13 mm | 172.13 mm | 172.13 mm | |
Cash burn (monthly) | (no burn) | (no burn) | 15.28 mm | 11.25 mm | 6.36 mm | |
Cash used (since last report) | n/a | n/a | 42.77 mm | 31.49 mm | 17.81 mm | |
Cash remaining | n/a | n/a | 129.36 mm | 140.64 mm | 154.32 mm | |
Runway (months of cash) | n/a | n/a | 8.5 | 12.5 | 24.2 |
13F holders | Current |
---|---|
Total holders | 161 |
Opened positions | 26 |
Closed positions | 39 |
Increased positions | 68 |
Reduced positions | 33 |
13F shares | Current |
---|---|
Total value | 2.53 tn |
Total shares | 73.35 mm |
Total puts | 330.10 k |
Total calls | 414.20 k |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
Biotechnology Value Fund L P | 12.66 mm | $329.17 mm |
Wellington Management | 7.77 mm | $341.02 bn |
FMR | 6.13 mm | $268.98 bn |
JHG Janus Henderson | 3.96 mm | $173.62 bn |
Capital Research Global Investors | 3.53 mm | $154.95 bn |
Driehaus Capital Management | 2.53 mm | $110.89 bn |
FHI Federated Hermes | 2.41 mm | $105.85 bn |
BVF | 2.24 mm | $98.27 bn |
T. Rowe Price | 2.08 mm | $91.50 mm |
Ra Capital Management | 1.90 mm | $83.25 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Sep 24 | Ashley Hall | Ordinary Shares | Grant | Acquire A | No | No | 0 | 67,290 | 0.00 | 67,290 |
18 Sep 24 | Ashley Hall | Share option Ordinary Shares | Grant | Acquire A | No | No | 12.75 | 82,890 | 1.06 mm | 82,890 |
18 Sep 24 | Crespo Blas Coll | Ordinary Shares | Grant | Acquire A | No | No | 0 | 90,600 | 0.00 | 102,600 |
18 Sep 24 | Crespo Blas Coll | Share option Ordinary Shares | Grant | Acquire A | No | No | 12.75 | 111,000 | 1.42 mm | 111,000 |